Global Eye Care Market Size, Share &; Forecast, By Product Type, Mode of Purchase & Distribution Channel, 2026-2031

The Global Eye Care Market is valued at USD 75.40 billion in 2025. The estimate covers commercial revenue from eyeglasses, contact lenses, intraocular lenses and ocular health products across retail, online and clinical channels. Revenue is anchored by recurring correction demand and expanding disease-management categories. The estimate is directionally consistent with current public benchmarks that place global vision care revenue near USD 71-76 billion under comparable product-based definitions.

The market is projected to reach USD 101.62 billion by 2031, representing a 5.10% CAGR from the 2025 base. Growth should be supported by rising diagnosed myopia, ageing-related cataract and retinal demand, higher use of specialty contact lenses, premium intraocular lenses and broader digital replenishment. The forecast assumes steady access expansion rather than a sudden coverage step-change, with value growth remaining above volume growth because of technology and product-mix improvement.

Profit pools are expected to shift from basic, undifferentiated correction toward specialty contact lenses, myopia management, premium intraocular lenses, preservative-free ocular surface products and connected diagnostic ecosystems. These categories combine clinical differentiation with recurring or procedure-linked revenue. Digital channels will also capture more replenishment economics, but pure online models will face limits where fitting, prescription verification and surgical decision support remain essential. Integrated manufacturers and omnichannel operators should therefore capture more value than commodity suppliers.

Affordability and delivery capacity are the most material constraints. Two of every three people in low-income countries who need eyeglasses remain without access, and one in two people globally who need cataract surgery do not receive it. Product availability alone is therefore insufficient. Market conversion requires screening, trained providers, prescription pathways, financing and trusted dispensing. Suppliers entering underserved markets must design lower-cost products around the full care pathway rather than relying on conventional urban retail distribution.

Asia Pacific offers the strongest strategic growth outlook, with an estimated 6.2% CAGR through 2031, although North America remains the largest revenue pool at approximately USD 24.0 billion in 2025. Asia Pacific benefits from population scale, high myopia prevalence, expanding optical retail networks and improving clinical capacity. However, pricing, reimbursement and regulatory structures vary substantially by country. Regional expansion should therefore use country-specific portfolios rather than a single Asia-wide go-to-market model.

The combination of ageing and rising myopia has the greatest long-term impact because it expands both chronic eye disease and lifelong correction demand. Nearly half of the global population could be myopic by 2050, while the share of people aged 65 and older continues to rise. This produces simultaneous growth in spectacles, contact lenses, cataract surgery, glaucoma monitoring, retinal diagnostics and ocular surface care. The breadth of this demand reduces dependence on any single product category.